Analysis of metabolic characteristics in different risk groups of thyroid nodules population

JIANG Shuqiang; QIN Yuhong; LI Ling

PDF(675 KB)

Medical Journal of the Chinese People Armed Police Forces ›› 2020, Vol. 31 ›› Issue (4) : 299-302.

ORIGINAL ARTICLES

Analysis of metabolic characteristics in different risk groups of thyroid nodules population

JIANG Shuqiang, QIN Yuhong, LI Ling

Author information +

History +

Abstract

Objective To evaluate thyroid nodules, wechat platform was used to study the relationship between different risk levels and metabolic indexes.Methods 584 subjects were selected to check thyroid ultrasound, height and weight, blood glucose, blood lipid, blood uric acid and thyroid function. The test data is imported into the thyroid risk assessment platform. 584 subjects were divided into three groups according to the assessment:non nodule group, low risk group, high risk group. Doctors collect the results of thyroid ultrasound and thyroid function examination from doctor’s client-side, check the risk assessment report, supervise the subjects.Results There was statistical difference in TT₄ between non nodule group and low risk group(H=4.936,P＜0.05).Age,serum uric acid,FT₃,FT₄ and TSH has significant statistical differences in two group(H=10.29,18.415,44.446,17.655,20.171,P＜0.01). There was statistical difference in FT₃ between non nodule group and high risk group(H=4.534,P＜0.05). All tests had no significant difference between the low-risk group and the high-risk group.Conclusions On different thyroid nodules risk levels,there were differences in serum uric acid and thyroid function,graded management of thyroid nodule population and early intervention was helpful.

Key words

thyroid nodule / risk assessment / metabolism

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

JIANG Shuqiang, QIN Yuhong, LI Ling. Analysis of metabolic characteristics in different risk groups of thyroid nodules population[J]. Medical Journal of the Chinese People Armed Police Forces. 2020, 31(4): 299-302

References

[1] 中华医学会内分泌学分会,中华医学会外科学分会内分泌学组,中国抗癌协会头颈肿瘤专业委员会,中华医学会核医学分会.甲状腺结节和分化型甲状腺癌诊治指南[J].中华内分泌代谢杂志,2012,28(10):779-797.
[2] 张波,徐景竹,吴琼.2015年美国甲状腺学会《成人甲状腺结节与分化型甲状腺癌诊治指南》解读:超声部分[J].中国癌症杂志,2016,26(1):19-24.
[3] 孙团起,吴毅.我国甲状腺结节的诊治现状与展望[J].中国普外基础与临床杂志,2014,21(9):1053-1055.
[4] Boelaert K, Horacek J, Holder R L,et al.Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration[J].J Clin Endocrinol Metab,2006,91(11):4295-4301.
[5] Polyzos S A,Kita M,Efstathiadou,et al.Serum thyrotropin concentration as a biochemical predictor of thyroid malignancy in patients presenting with thyroid nodules[J].J Cancer Res Clin Oncol,2008,134(9):953-960.
[6] Jin J,Machekano R,Mchenry C R.The utility of preoperative serum thyroid-stimulating hormone level for predicting malignant nodular thyroid disease[J].Am J Surg,2010,199:294-297.
[7] 曾泉,刘杰,朱江,等.术前血清促甲状腺素水平预测正常功能甲状腺结节性质的作用分析[J].临床耳鼻咽喉头颈外科杂志,2014,28(24):1931-1933.
[8] 闫慧娴,谷伟军,杨国庆,等. 血清促甲状腺激素与甲状腺乳头状微小癌相关性研究[J].中华内分泌代谢杂志,2014,30(8):669-672.
[9] 柳林,卢洪文,冯剑,等.健康体检者7097名甲状腺结节检出情况与临床特点[J].中华临床医师杂志(电子版),2014,8(14):2663-2667.
[10] 李伟.职工体检甲状腺结节调查及3年随访分析[J].实用糖尿病杂志,2014,10(5):48-49.
[11] Sponziello M L, Bruno R, Durante C,et al.Growth factor receptors gene expression and Akt phosphorylation in benign human thyroid nodules are unaffected by chronic thyrotropin suppression[J].Horm Metab Res,2011,43(1):22-25.
[12] 王晓艳,王亚军,蒿花,等.甲状腺结节与代谢综合征相关组分的临床研究[J].西安交通大学学报(医学版),2017,38(1):151-153.
[13] 冷松,刘颖,赵辉,等.代谢综合征及其组分与甲状腺结节相关性的研究[J].中华健康管理学杂志,2011,5(4),211-214.
[14] 张春玉,曾洪利,刘颖,等.甲状腺结节与代谢综合征及其组分的相关性分析[J].中华内分泌代谢杂志,2012,28(2):132-135.
[15] 张艳町,吴霞,牛久欣,等.深州市健康体检人群甲状腺结节患病率及相关因素分析[J].河北医药,2014 ,36(22):3482-3483.
[16] 席燕,王月香.老年高血压患者促甲状腺激素水平及临床意义[J].中国老年学杂志,2013,33(6):1425-1426.
[17] 田晓玲,李彩艳,林凤平,等.代谢综合征患者甲状腺结节患病情况分析[J].中国临床保健杂志,2015,18(3):264-266.
[18] Bétry C,Challan-Belval M A,Bernard A,et al.Increased TSH in obesity:Evidence for a BMI-dependent association with leptin[J].Diabetes Metab,2015,41(3):248-251.
[19] Rezzónico J,Rezzónico M,Pusiol E,et al.Metformin treatment for small benign thyroid nodules in patients with insulin resistance[J].Metab Syndr Relat Disord,2011,9(1):69-75.
[20] 王博,刘珺,张玄娥,等.糖代谢异常与甲状腺结节相关性研究[J].中国全科医学,2015,18(30): 3648-3652.